These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 31144792)
21. Non-contrast cardiac CT immediately after percutaneous coronary intervention: does it predict the risk of left ventricular remodeling in patients with ST-elevation myocardial infarction? Khurelsukh K; Kim YH; Seon HJ; Song JH; Park SY; Moon SM; Kim SH; Sim DS; Ahn Y Int J Cardiovasc Imaging; 2016 Jun; 32 Suppl 1():147-54. PubMed ID: 27139462 [TBL] [Abstract][Full Text] [Related]
22. Nonmyocardial production of ST2 protein in human hypertrophy and failure is related to diastolic load. Bartunek J; Delrue L; Van Durme F; Muller O; Casselman F; De Wiest B; Croes R; Verstreken S; Goethals M; de Raedt H; Sarma J; Joseph L; Vanderheyden M; Weinberg EO J Am Coll Cardiol; 2008 Dec; 52(25):2166-74. PubMed ID: 19095135 [TBL] [Abstract][Full Text] [Related]
23. Circulating CTRP1 Levels Are Increased and Associated with the STOD in Essential Hypertension in Chinese Patients. Su Z; Tian S; Liang W Cardiovasc Ther; 2019; 2019():4183781. PubMed ID: 31772610 [TBL] [Abstract][Full Text] [Related]
24. Serum cardiac troponin and subclinical cardiac status in pediatric chronic renal failure. Lipshultz SE; Somers MJ; Lipsitz SR; Colan SD; Jabs K; Rifai N Pediatrics; 2003 Jul; 112(1 Pt 1):79-86. PubMed ID: 12837871 [TBL] [Abstract][Full Text] [Related]
25. Serum biomarkers and clinical outcomes in heart failure patients treated de novo with carvedilol. Nessler J; Nessler B; Golebiowska-Wiatrak R; Palka I; Gackowski A; Kitlinski M; Melander O; Fedorowski A Cardiol J; 2013; 20(2):144-51. PubMed ID: 23558872 [TBL] [Abstract][Full Text] [Related]
26. Disorders of left ventricular structure and function in chronic uremia: how often, why and what to do with it? Dyadyk OI; Bagriy AE; Yarovaya NF Eur J Heart Fail; 1999 Dec; 1(4):327-36. PubMed ID: 10937946 [TBL] [Abstract][Full Text] [Related]
27. First trimester inflammatory mediators in women with chronic hypertension. Nzelu D; Dumitrascu-Biris D; Karampitsakos T; Nicolaides KK; Kametas NA Acta Obstet Gynecol Scand; 2020 Sep; 99(9):1198-1205. PubMed ID: 32237233 [TBL] [Abstract][Full Text] [Related]
28. Sildenafil preserves lung endothelial function and prevents pulmonary vascular remodeling in a rat model of diastolic heart failure. Yin J; Kukucka M; Hoffmann J; Sterner-Kock A; Burhenne J; Haefeli WE; Kuppe H; Kuebler WM Circ Heart Fail; 2011 Mar; 4(2):198-206. PubMed ID: 21216837 [TBL] [Abstract][Full Text] [Related]
29. Effects of irbesartan on phenotypic alterations in monocytes and the inflammatory status of hypertensive patients with left ventricular hypertrophy. Zhang J; Yang L; Ding Y BMC Cardiovasc Disord; 2021 Apr; 21(1):194. PubMed ID: 33879070 [TBL] [Abstract][Full Text] [Related]
30. [Impact of left ventricular patterns and diastolic dysfunction on hemodialysis patients]. Gagliardi GM; Rossi S; Manes MT; Gerace G; Martire V; Caruso F; Vocaturo G; De Napoli N G Ital Nefrol; 2004; 21(1):45-50. PubMed ID: 15356847 [TBL] [Abstract][Full Text] [Related]
31. Cardiac structure and function in renal disease. Amann K; Ritz E Curr Opin Nephrol Hypertens; 1996 Jan; 5(1):102-6. PubMed ID: 8834168 [TBL] [Abstract][Full Text] [Related]
32. Endothelial dysfunction in uremic patients on continuous ambulatory peritoneal dialysis (CAPD). Rašić S; Hadžović-Džuvo A; Rebić D; Valjevac A; Unčanin S Bosn J Basic Med Sci; 2011 Aug; 11(3):153-7. PubMed ID: 21875416 [TBL] [Abstract][Full Text] [Related]
33. Effects of Puerarin on Clinical Parameters, Vascular Endothelial Function, and Inflammatory Factors in Patients with Coronary Artery Disease. Zhang S; Chen L; Zhou Z; Fan W; Liu S Med Sci Monit; 2019 Jan; 25():402-408. PubMed ID: 30636768 [TBL] [Abstract][Full Text] [Related]
34. The role of inflammation in heart failure: new therapeutic approaches. Oikonomou E; Tousoulis D; Siasos G; Zaromitidou M; Papavassiliou AG; Stefanadis C Hellenic J Cardiol; 2011; 52(1):30-40. PubMed ID: 21292605 [No Abstract] [Full Text] [Related]
35. Novel markers of left ventricular hypertrophy in uremia. Nakamura H; Tokumoto M; Mizobuchi M; Ritter CS; Finch JL; Mukai M; Slatopolsky E Am J Nephrol; 2010; 31(4):292-302. PubMed ID: 20130393 [TBL] [Abstract][Full Text] [Related]
36. Visfatin is related to lipid dysregulation, endothelial dysfunction and atherosclerosis in patients with chronic kidney disease. Mu J; Feng B; Ye Z; Yuan F; Zeng W; Luo Z; Qi W J Nephrol; 2011; 24(2):177-84. PubMed ID: 20602330 [TBL] [Abstract][Full Text] [Related]
37. Biomarkers of cardiovascular remodeling in patients on peritoneal dialysis. Rebić D; Rašić S; Valjevac A; Unčanin S; Hamzić-Mehmedbašić A Am J Nephrol; 2014; 39(2):92-9. PubMed ID: 24503489 [TBL] [Abstract][Full Text] [Related]
38. Activation of SUR2B/Kir6.1 subtype of adenosine triphosphate-sensitive potassium channel improves pressure overload-induced cardiac remodeling via protecting endothelial function. Tang Y; Long CL; Wang RH; Cui W; Wang H J Cardiovasc Pharmacol; 2010 Oct; 56(4):345-53. PubMed ID: 20505525 [TBL] [Abstract][Full Text] [Related]
39. Vascular biology in uremia: insights into novel mechanisms of vascular injury. Al Aly Z; Edwards JC Adv Chronic Kidney Dis; 2004 Jul; 11(3):310-8. PubMed ID: 15241745 [TBL] [Abstract][Full Text] [Related]